Clinical Trials on CHD Risk-Equivalent Disease in Australia
Total 80 results
-
Monash UniversityNovartis PharmaceuticalsRecruitingCerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)Australia
-
University of AdelaideCompletedIndividuals at Risk of Developing DiabetesAustralia
-
Azura OphthalmicsThe University of New South WalesCompletedMeibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)Australia
-
University of Colorado, DenverNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsRecruitingCDKL5 | CDKL5 Deficiency Disorder | CDDUnited States, Australia
-
Monash UniversityRecruitingCardiovascular Risk Factors | Cognitive Function 1, Social | Poor Glycemic ControlAustralia
-
Flinders Universitymedac GmbH; University of South AustraliaRecruitingRheumatoid Arthritis | Endothelial Dysfunction | Cardiovascular Risk Factor | Stiffness, AorticAustralia
-
Medical University of GrazMedical University of ViennaUnknownPrevalent OPG and RANKL Excession in Patients With CADAustria
-
Bayside HealthCompletedLength of ICU Stay | Pressure Ulcer, Area | Pressure Ulcer, Grade | Albumin Level | Risk ScoreAustralia
-
Medical University of ViennaUnknownFluid Overload | Cardiovascular Risk Factor | Valvular Heart DiseaseAustria
-
Medical University of ViennaUnknown
-
EBG MedAustron GmbHRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria
-
OrygenNational Institute of Mental Health (NIMH); University of California, Davis; University...UnknownPersonality Disorders | Psychotic Disorders | Clinical High RiskAustralia
-
University of OxfordBritish Heart Foundation; European Commission; Oxford University Hospitals NHS... and other collaboratorsRecruitingCardiovascular Diseases | Cardiovascular Risk FactorsUnited Kingdom, Germany, Belgium, China, United States, Australia, France, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Romania, United Arab Emirates
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
The University of QueenslandActive, not recruitingNeoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Non-small Cell Lung Cancer | Smokers at Risk of Lung CancerAustralia, Canada
-
Royal North Shore HospitalRecruiting
-
Gold Coast Hospital and Health ServiceBod AustraliaActive, not recruitingMotor Neuron Disease | Amyotrophic Lateral Sclerosis | Cannabis | CBDAustralia
-
Cymra Life SciencesCompletedPain | Back Pain | Chronic Pain | Neck Pain | Pain, Chronic | CBD | Pain, Back | Pain, Neck | THCAustralia
-
Paracelsus Medical UniversityCompletedCardiovascular Risk Factor | SCI - Spinal Cord InjuryAustria
-
Medical University of ViennaUnknownType 2 Diabetes Mellitus | Endothelial Dysfunction | Cardiovascular RiskAustria
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
Medical University InnsbruckActive, not recruitingCoronary Artery Disease | Peripheral Artery Disease | Cardiovascular Risk Factors | Cerebrovascular DiseaseAustria
-
Medical University of GrazCompletedCritical Illness | Covid19 | Risk Factor, Cardiovascular | Course IllnessAustria
-
AmgenCompletedCoronary Artery Disease (CAD)Australia, Czechia, Italy, United States, Netherlands, Hungary, Germany
-
SanofiBristol-Myers SquibbCompletedAtrial Fibrillation | Vascular RiskUnited States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
-
SanofiBristol-Myers SquibbTerminatedAtrial Fibrillation | Vascular RiskUnited States, France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Denmark, Finland, H... and more
-
Medical University of ViennaCompletedRegional Blood Flow | Optic DiskAustria
-
AstraZenecaThrombolysis in Myocardial Infarction (TIMI) Study GroupCompletedCoronary Heart Disease (CHD)United States, Italy, Netherlands, Spain, Japan, Czechia, Hungary, Australia, Poland, Canada, United Kingdom
-
AmgenActive, not recruitingCoronary Heart Disease (CHD)Canada, France, United States, Spain, United Kingdom, Korea, Republic of, Netherlands, Austria, Australia, Czechia, Taiwan, Finland, Hungary, Italy, Poland, Greece, Germany, Brazil, Latvia, Denmark, Mexico, Russian Federation, Bulgaria and more
-
Moritz OberndorferMerck Gesellschaft mbH, AustriaCompletedHIV Infections | Diabetes Mellitus | Dyslipidemias | Cardiovascular Risk FactorAustria
-
Clinical Hospital Centre ZagrebEuropean Society of HypertensionUnknownWhite Coat Hypertension | Blood Pressure | Lifestyle Risk ReductionIsrael, Greece, Belgium, Germany, Armenia, Austria, Bulgaria, Croatia, Czechia, Estonia, Italy, Lebanon, Lithuania, Netherlands, Poland, Portugal, Romania, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
Klinikum Wels-GrieskirchenGenzyme, a Sanofi CompanyCompletedFocus of Study: Prevalence of Fabry Disease in CKD PopulationAustria
-
VASCage GmbHMedical University Innsbruck; Tirol Kiniken GmbHCompletedCardiovascular Diseases | Vascular Diseases | Hypertension | Obesity | Overweight | Sleep Disorder | Atherosclerosis | Sleep | Headache | Vascular Stiffness | Cardiovascular Risk Factor | Non-Alcoholic Fatty Liver Disease | Life Style | Cardiovascular PathologyAustria
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Novartis PharmaceuticalsCompletedChronic Heart Failure (CHF)Spain, Croatia, Taiwan, Germany, Italy, United States, Australia, Netherlands, Switzerland, Belgium, United Kingdom, Bulgaria, Lithuania, Russian Federation, France, Argentina, Korea, Republic of, Poland, Canada, Turkey
-
Medical University of ViennaCompletedSecondary Hyperparathyroidism | CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder | Kidney ReplacementAustria
-
Bergman ClinicsMICN Lab, University Hospital ZurichCompletedLow Back Pain | Disk Herniated Lumbar | Spinal Stenosis LumbarFrance, Austria, Netherlands
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
Medtronic BRCCompletedAtrial Fibrillation | Risk of Cardiac ArrhythmiasNetherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
-
Bioverativ, a Sanofi companyAssign Data Management and Biostatistics GmbH; Quest Diagnostics-Nichols Insitute and other collaboratorsCompletedEnd-stage Renal Disease (ESRD) | Cold Agglutinin Disease (CAD) | Bullous Pemphigoid (BP) | Warm Autoimmune Hemolytic Anemia (WAIHA)Austria
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
ECRI bvAstraZeneca; The Medicines Company; Biosensors InternationalCompletedCoronary Artery Disease (CAD)Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Singapore, Spain, Switzerland, United Kingdom
-
Trans Tasman Radiation Oncology GroupCompletedNasopharyngeal Cancer | Anal Cancer | Intermediate Risk Prostate Cancer | Prostate Cancer (Post Prostatectomy)Australia
-
Amsterdam UMCRecruitingBarrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaNetherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownBarrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaFrance, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia